Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
Inventor creates tiny technologies for medicine; awarded $500,000 Lemelson-MIT Prize
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
Engineering new bone growth
Coated tissue scaffolds help the body grow new bone to repair injuries or congenital defects.
A new way to model cancer
New gene-editing technique allows scientists to more rapidly study the role of mutations in tumor development.
Model of viral lifecycle could help in finding a cure for hepatitis B
New technique sustains virus in liver cells, allowing study of immune response and drug treatments.
Advanced thin-film technique could deliver long-lasting medication
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Tracking oxygen in the body
MRI sensor that enables long-term monitoring of oxygen levels could aid cancer diagnosis and treatment.
Targeting cancer with a triple threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.